(Q35065315)

6 August 2017

1 reference

title

Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome? (English)

1 reference

inflammatory bowel diseases

6 August 2017

main subject

1 reference

inferred from title

author name string

Fernando Tavarela Veloso

series ordinal

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 June 2011

1 reference

World Journal of Gastroenterology

6 August 2017

published in

1 reference

6 August 2017

volume

17

1 reference

6 August 2017

issue

22

1 reference

6 August 2017

page(s)

2702-2707

1 reference

Spondyloarthropathy and idiopathic inflammatory bowel diseases

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Mycophenolate mofetil as therapy for pyoderma gangrenosum.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Extraintestinal manifestations in inflammatory bowel disease.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Important cutaneous manifestations of inflammatory bowel disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Review article: skin complications associated with inflammatory bowel disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Review article: joint involvement in inflammatory bowel disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

THE EXTRA-INTESTINAL COMPLICATIONS OF CROHNʼS DISEASE AND ULCERATIVE COLITIS: A STUDY OF 700 PATIENTS

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Development and validation of novel diagnostic criteria for intestinal Behçet's disease in Korean patients with ileocolonic ulcers.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Topical treatment of pyoderma gangraenosum.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Tacrolimus to treat pyoderma gangrenosum resistant to cyclosporine.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Clinical and imaging correlates of response to treatment with infliximab in patients with ankylosing spondylitis

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122258

Treatment of pyoderma gangrenosum associated with Crohn's disease

16 November 2018

1 reference

12 December 2020

Treatment of acute uveitis associated with Crohn's disease and sacroileitis with infliximab

1 reference

12 December 2020

Clinical outcome of Crohn's disease: analysis according to the vienna classification and clinical activity

1 reference

12 December 2020

The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study

1 reference

12 December 2020

Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms

1 reference

12 December 2020

Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum

1 reference

12 December 2020

Primary sclerosing cholangitis

1 reference

12 December 2020

Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response

1 reference

12 December 2020

1 reference

12 December 2020

The association of autoimmune disorders with inflammatory bowel disease

1 reference

12 December 2020

Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn's disease

1 reference

12 December 2020

Anti-TNF therapies in the management of acute and chronic uveitis

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V17.I22.2702

1 reference

6 August 2017

1 reference

6 August 2017

1 reference